Zoliflodacin has exhibited low cross-resistance with FQ-resistant and ceftriaxone- and azithromycinresistant in strains of N gonorrhoeae around the world. Here is a review of this recently approved antibiotic.
Christina Yen, MD, MBE
Advertisement
Yen is an infectious diseases specialist and medical director of antimicrobial stewardship at Maine Medical Center in South Portland, Maine.
Articles by Christina Yen, MD, MBE
Understanding the potential and limitations of new Acinetobacter baumannii active therapies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Assigns Highest-Risk Classification to Salmonella Egg Recall
2
Update on Cyclosporiasis: Over 15,000 Cases, Expands to 47 States
3
Why Measles Cases Are Up: US Childhood Vaccine Rates Drop, Immunization Exemptions Increase
4
When Daptomycin Fails: Practical Approaches to Resistant Enterococcus faecium
5